Evidence map›Paper›PMID 27725907›Full record

ArticleAmerican journal of cancer research2016

miR-489 acts as a tumor suppressor in human gastric cancer by targeting PROX1.

Bin Zhang, Sheqing Ji, Fei Ma, Qi Ma, Xianzhi Lu, Xiaobing Chen

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bin ZhangDepartment of General Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, China.
Sheqing JiDepartment of General Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, China.
Fei MaDepartment of General Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, China.
Qi MaDepartment of General Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, China.
Xianzhi LuDepartment of General Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, China.
Xiaobing ChenDepartment of General Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, China.
Henan Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysregulation of microRNAs (miRNAs) are linked to tumorigenesis and tumor progression. In this study, we examined the expression of miR-489 in gastric cancer tissues and cells. Loss- and gain-of-function experiments were done to determine the roles of miR-489 in gastric cancer cell proliferation and invasion. Bioinformatic prediction, luciferase reporter assays, and Western blot analysis were employed to identify the target gene(s) of miR-489. We found that miR-489 was significantly (

Indexed as

Gastric cancerinvasivenessmicroRNAtarget genestumorigenesis

Identifiers

PMID27725907
PMCPMC5043111
OpenAlexW2538155026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.